Search research articles
Contact Us
Filters
Showing results (41-50 of 65) with videos related to
Page
of 7
Sort By:
Molecular Pharmacology
|
August 5, 2006
Inhibition of in vivo glioma growth and invasion by peroxisome proliferator-activated receptor gamma agonist treatment
Christian Grommes, Gary E Landreth, Magdalena Sastre, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
May 11, 2024
Histone deacetylase-3 regulates the expression of the amyloid precursor protein and its inhibition promotes neuroregenerative pathways in Alzheimer's disease models
Nicola Davis, Ben Taylor, Laura Abelleira-Hervas, et al.
Neurobiology of Aging
|
October 16, 2012
Prazosin, an α(1)-adrenoceptor antagonist, prevents memory deterioration in the APP23 transgenic mouse model of Alzheimer's disease
Loukia Katsouri, Marcela P Vizcaychipi, Simon McArthur, et al.
Scientific Reports
|
June 22, 2021
Multiscale modelling of cerebrovascular injury reveals the role of vascular anatomy and parenchymal shear stresses
Siamak Farajzadeh Khosroshahi, Xianzhen Yin, Cornelius K Donat, et al.
Acta Neuropathologica Communications
|
January 29, 2021
Tau-proximity ligation assay reveals extensive previously undetected pathology prior to neurofibrillary tangles in preclinical Alzheimer's disease
Nora Bengoa-Vergniory, Elisavet Velentza-Almpani, Ana Maria Silva, et al.
Glia
|
March 10, 2016
In vivo imaging of microglial activation by positron emission tomography with [(11)C]PBR28 in the 5XFAD model of Alzheimer's disease
Nazanin Mirzaei, Sac Pham Tang, Sharon Ashworth, et al.
Neurobiology of Aging
|
June 24, 2004
Binding of cystatin C to Alzheimer's amyloid beta inhibits in vitro amyloid fibril formation
Magdalena Sastre, Miguel Calero, Monika Pawlik, et al.
Brain : a Journal of Neurology
|
April 9, 2005
Acute treatment with the PPARgamma agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta1-42 levels in APPV717I transgenic mice
Michael T Heneka, Magdalena Sastre, Lucia Dumitrescu-Ozimek, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 30, 2016
PPARγ-coactivator-1α gene transfer reduces neuronal loss and amyloid-β generation by reducing β-secretase in an Alzheimer's disease model
Loukia Katsouri, Yau M Lim, Katrin Blondrath, et al.
Journal of Neuroinflammation
|
March 18, 2021
Pharmacological ablation of astrocytes reduces Aβ degradation and synaptic connectivity in an ex vivo model of Alzheimer's disease
Nicola Davis, Bibiana C Mota, Larissa Stead, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 65) with videos related to
Sort By:
Page
of 7
Molecular Pharmacology
|
August 5, 2006
Inhibition of in vivo glioma growth and invasion by peroxisome proliferator-activated receptor gamma agonist treatment
Christian Grommes, Gary E Landreth, Magdalena Sastre, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
May 11, 2024
Histone deacetylase-3 regulates the expression of the amyloid precursor protein and its inhibition promotes neuroregenerative pathways in Alzheimer's disease models
Nicola Davis, Ben Taylor, Laura Abelleira-Hervas, et al.
Neurobiology of Aging
|
October 16, 2012
Prazosin, an α(1)-adrenoceptor antagonist, prevents memory deterioration in the APP23 transgenic mouse model of Alzheimer's disease
Loukia Katsouri, Marcela P Vizcaychipi, Simon McArthur, et al.
Scientific Reports
|
June 22, 2021
Multiscale modelling of cerebrovascular injury reveals the role of vascular anatomy and parenchymal shear stresses
Siamak Farajzadeh Khosroshahi, Xianzhen Yin, Cornelius K Donat, et al.
Acta Neuropathologica Communications
|
January 29, 2021
Tau-proximity ligation assay reveals extensive previously undetected pathology prior to neurofibrillary tangles in preclinical Alzheimer's disease
Nora Bengoa-Vergniory, Elisavet Velentza-Almpani, Ana Maria Silva, et al.
Glia
|
March 10, 2016
In vivo imaging of microglial activation by positron emission tomography with [(11)C]PBR28 in the 5XFAD model of Alzheimer's disease
Nazanin Mirzaei, Sac Pham Tang, Sharon Ashworth, et al.
Neurobiology of Aging
|
June 24, 2004
Binding of cystatin C to Alzheimer's amyloid beta inhibits in vitro amyloid fibril formation
Magdalena Sastre, Miguel Calero, Monika Pawlik, et al.
Brain : a Journal of Neurology
|
April 9, 2005
Acute treatment with the PPARgamma agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta1-42 levels in APPV717I transgenic mice
Michael T Heneka, Magdalena Sastre, Lucia Dumitrescu-Ozimek, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 30, 2016
PPARγ-coactivator-1α gene transfer reduces neuronal loss and amyloid-β generation by reducing β-secretase in an Alzheimer's disease model
Loukia Katsouri, Yau M Lim, Katrin Blondrath, et al.
Journal of Neuroinflammation
|
March 18, 2021
Pharmacological ablation of astrocytes reduces Aβ degradation and synaptic connectivity in an ex vivo model of Alzheimer's disease
Nicola Davis, Bibiana C Mota, Larissa Stead, et al.
Page
of 7